APA (7th ed.) Citation

LI, C., WANG, M., LIANG, L., XING, H., YAO, L., CHEN, Z., . . . YANG, T. (2022). Multi-institutional development and validation of modified albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy. Annals of hepato-biliary-pancreatic surgery, 26(Suppl 1), 307. https://doi.org/10.14701/ahbps.2022S1.EP-25

Chicago Style (17th ed.) Citation

LI, Chao, Ming-Da WANG, Lei LIANG, Hao XING, Lan-Qing YAO, Zi-Xiang CHEN, Feng SHEN, Dong-Sheng HUANG, and Tian YANG. "Multi-institutional Development and Validation of Modified Albumin-bilirubin Grade for Predicting Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy." Annals of Hepato-biliary-pancreatic Surgery 26, no. Suppl 1 (2022): 307. https://doi.org/10.14701/ahbps.2022S1.EP-25.

MLA (9th ed.) Citation

LI, Chao, et al. "Multi-institutional Development and Validation of Modified Albumin-bilirubin Grade for Predicting Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy." Annals of Hepato-biliary-pancreatic Surgery, vol. 26, no. Suppl 1, 2022, p. 307, https://doi.org/10.14701/ahbps.2022S1.EP-25.